Worldwide Impact of Respiratory Cancers in 2022 and Projections for 2050: Incidence and Mortality Data from GLOBOCAN - Top-Institutions - MDSpire

Worldwide Impact of Respiratory Cancers in 2022 and Projections for 2050: Incidence and Mortality Data from GLOBOCAN

  • By

  • Yuhua Wang

  • Feng Yu

  • Feng Qiu

  • Ke Fang

  • November 28, 2025

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Medical Oncology
    • Thoracic Surgery
    • Cancer Epidemiology

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Medical Oncology
    • Radiation Oncology
    • Cancer Prevention

  • #3

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Medical Oncology
    • Cancer Genomics
    • Translational Research

  • #4

    National Cancer Institute (NCI)
    National Cancer Institute (NCI)

    Bethesda, MD

    Key Differentiators

    • Cancer Epidemiology
    • Clinical Trials
    • Public Health

  • #5

    University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical Center

    Dallas, TX

    Key Differentiators

    • Thoracic Oncology
    • Molecular Biology
    • Clinical Research

Original Source(s)

Worldwide Impact of Respiratory Cancers in 2022 and Projections for 2050: Incidence and Mortality Data from GLOBOCAN

  • by Yuhua Wang, Feng Yu, Feng Qiu, Ke Fang

  • November 28, 2025

Related Content

Beyond inhibition: harnessing the DRD2–VEGF-A feedback loop for precision anti-angiogenesis therapy in cancer

Synthetic short RNA in cancer

Data requirements of an informative, directive, and preventive mobile health application for gastric cancer